Tag: CRISPR therapeutics
March 20, 2020
The Rise of CRISPR Technology
CRISPR technology is a rapidly growing component of the genetics industry. Here's what investors need to know about its future...
November 24, 2019
5 Top NASDAQ Biotech and Pharma Stocks: Fulcrum Climbs 73 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 19, 2019
CRISPR and Vertex Release Positive Gene-editing Results
This is the first time CRISPR/Cas9 gene-editing technology has been used in human trials to treat genetic diseases.
July 2, 2019
5 Top Biotechnology ETFs
For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration. February 25, 2019
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
CRISPR Therapeutics (NASDAQ:CRSP) has announced financial results for its fourth quarter and full year ended December 31, 2018. As quoted...
November 13, 2018
CRISPR Trials to Watch in 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress. October 11, 2018